You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Development of An Integrated High Throughput Imaging and Image Analysis Platform for Muscle

    SBC: CytoInformatics LLC            Topic: NIA

    DESCRIPTION provided by applicant There is growing awareness that weakness of muscle is a significant biomedical health issue associated with many different chronic diseases and aging There are a variety of different diseases that affect muscle including muscular dystrophy fibromyalgia cerebral palsy amyotrophic lateral sclerosis and myasthenia gravis each of which carries its own uniqu ...

    STTR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health
  2. Distance Filtering System for Retinal Implants

    SBC: ADVANCED MEDICAL ELECTRONICS CORP            Topic: N

    DESCRIPTION provided by applicant We propose to develop and evaluate the utility of a novel input camera system for retinal prosthetics that allows users to filter optical imagery based on distance from the observer We call this andquot depth filteringandquot which can be accomplished with a depth sensing stereoscopic camera system Retinal prostheses can restore partial vision to people bli ...

    STTR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health
  3. Painless, Bloodless And Safe Glucose Sensing System For The Pediatric Intensive Care Unit

    SBC: Fluorometrix Biomedical Company            Topic: NICHD

    DESCRIPTION provided by applicant Studies in the pediatric intensive care unit PICU have shown that hypoglycemia hyperglycemia as well as swings in blood glucose levels are strongly associated with higher morbidity and mortality However tight glucose control has not been proven as effective In fact hypoglycemia was found to be a real danger Thus there is a need for more careful study ...

    STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  4. B7-H3-Targeted Contrast Agent for Ultrasonic Imaging of Breast Cancer

    SBC: NUVOX PHARMA, L.L.C.            Topic: 102

    ABSTRACT Breast cancer is the second leading cause of cancer deaths in women in the United States and early detection can help improve survival While mammography is the current first line imaging technique for early breast cancer detection its diagnostic accuracy is limited in women with dense breast tissue Ultrasound is often performed as a second line test in women with dense breast tissue H ...

    STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  5. Ultrahigh Performance Non-Denaturing Protein Chromatography Columns

    SBC: BIOVIDRIA, INC.            Topic: 400

    PROJECT SUMMARY The proposed product is an analytical scale UHPLC column for separating protein drugs in native form with the Phase I proposal focused on anion exchange chromatography as the separation mechanism The bonded phase is made of polymer chains in this case bearing weak anion exchange groups The study will be expanded to cation exchange and hydrophobic interaction chromatography in ...

    STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  6. Target Identification for Novel Small Molecule Therapeutic for Alzheimer's disease

    SBC: CoPlex Therapeutics, LLC            Topic: NIA

    ABSTRACT Traditional approaches to drug development for Alzheimer s disease are becoming increasingly expensive and in many cases disappointingly unsuccessful Based on preliminary in vitro and in vivo studies we have identified a novel small molecule methyl dimethyl oxo dihydrobenzo c naphthyridine carboxylate UK that significantly decreases A production and pro in ...

    STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  7. Snapshot Imaging Laser Displacement Sensor for Hypersonic Diagnostic Testing

    SBC: Control Vision, Inc.            Topic: AF15AT38

    The Air Force is interested in hypersonic (M>5) systems that enable time-critical missions for strike and Intelligence, Surveillance, Reconnaissance (ISR). Perhaps more so than for any other flight regime, precise and accurate sensing of key phenomena is difficult without contaminating the data being collected. During the Phase I program, Control Vision, Inc developed unique optical profilometry t ...

    STTR Phase II 2016 Department of DefenseAir Force
  8. Highly specific ATR inhibitors for the targeted treatment of a broad spectrum of cancers

    SBC: Atrin Pharmaceuticals            Topic: 103

    PROJECT SUMMARY Specific targeting of the Ataxia Telangiectasia and Rad related kinase ATR represents an emerging strategy to treat a broad spectrum of cancers most notably those that currently lack effective treatments Suppression of ATR selectively kills cells subjected to oncogenic stress alternative lengthening of telomeres ALT or loss of double strand break DSB repair mechanisms A ...

    STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  9. In vitro human model for individualized response to CFTR modulators

    SBC: PROGENRA INC            Topic: NHLBI

    DESCRIPTION provided by applicant The approval of the cystic fibrosis CF drug invocator for patients with the G D mutation validates CFTR modulators for improving clinical outcomes in CF For most CF patients with F del and other mutations however multi drug combination therapy will likely be necessary and sensitive biomarkers of augmented CFTR function in response to various agents ...

    STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  10. Combinatorial Inactivation of ERBB Receptors in Breast Cancer using Therapeutic Stapled Peptides

    SBC: ARIZONA CANCER THERAPEUTICS L.L.C.            Topic: 103

    DESCRIPTION provided by applicant In metastatic breast cancer the Epidermal Growth Factor Receptor family of transmembrane tyrosine kinases ErbB drives proliferation and metastasis EGFR HER and ErbB are known to be highly expressed and active in both the HER and Triple Negative Basal subtypes of breast cancer and have been targeted with varying effectiveness Importantly targeting of ...

    STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government